Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 43601-43650 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06759961
Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant Centre
N/A
Recruiting
250 participants
Started: Feb 1, 2023 · Completed: Feb 1, 2033
2 conditions
1 sponsor
1 location
NCT05732389
Immunotherapy in Patients With Early dMMR Rectal Cancer
PHASE2
Recruiting
39 participants
Started: Feb 1, 2023 · Completed: Feb 29, 2052
1 condition
8 sponsors
5 locations
NCT05652673
Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
NA
Recruiting
80 participants
Started: Feb 1, 2023 · Completed: Dec 1, 2029
4 conditions
1 sponsor
1 location
NCT05567068
Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
PHASE2
Recruiting
44 participants
Started: Feb 1, 2023 · Completed: Sep 20, 2027
1 condition
1 sponsor
1 location
NCT05171686
Diuretics and Volume Overload in Early CKD
PHASE4
Recruiting
46 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05728957
Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
N/A
Recruiting
100 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2033
3 conditions
1 sponsor
1 location
NCT05734274
Clinical Effects of Limosilactobacillus Reuteri Probiotics as an Adjunct to the Treatment of Periodontitis
NA
Recruiting
60 participants
Started: Feb 1, 2023 · Completed: Jul 31, 2024
1 condition
1 sponsor
1 location
NCT05884983
Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma
N/A
Recruiting
12,000 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05719519
Change in Gingival Volume and Quality of Life Due to Initial Periodontal Therapy in Smokers
NA
Recruiting
60 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05193305
Study of Healthy Cohort for Early Detection of Cancer
N/A
Recruiting
10,000 participants
Started: Feb 1, 2023 · Completed: Feb 28, 2043
1 condition
2 sponsors
1 location
NCT05419726
Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.
N/A
Recruiting
20 participants
Started: Feb 1, 2023 · Completed: Feb 1, 2026
1 condition
1 sponsor
1 location
NCT05464368
R21 Roche: 3-Way Tau Tracers in AD
PHASE1
Recruiting
38 participants
Started: Feb 1, 2023 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT05738720
Effect of Home Based Pulmonary Rehabilitation on Exacerbation and Hospital Admission in Severe COPD
NA
Recruiting
24 participants
Started: Feb 1, 2023 · Completed: Dec 20, 2026
1 condition
1 sponsor
1 location
NCT06330675
Correct Mobilization Time After Implantation of an Intracardiac Electronic Device Implantation
NA
Recruiting
558 participants
Started: Feb 1, 2023 · Completed: Jun 1, 2027
2 conditions
2 sponsors
1 location
NCT05643209
Brugada Syndrome Substrate Characterization and Ablation
NA
Recruiting
20 participants
Started: Feb 1, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04433052
Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients With High Risk Stable CHD
NA
Recruiting
12,000 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
26 locations
NCT06243432
Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer
N/A
Recruiting
600 participants
Started: Feb 1, 2023 · Completed: Mar 1, 2025
1 condition
1 sponsor
1 location
NCT05362370
Stryker PEEK Customized Implant: A Prospective Post Market Follow Up to Evaluate Safety, Performance and Effectiveness
N/A
Recruiting
110 participants
Started: Feb 1, 2023 · Completed: Dec 30, 2027
3 conditions
2 sponsors
13 locations
NCT05370118
Improving Physical Activity With Cognitive Impairment
NA
Recruiting
60 participants
Started: Feb 1, 2023 · Completed: Jun 30, 2025
2 conditions
2 sponsors
1 location
NCT05509166
Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health
NA
Recruiting
450 participants
Started: Feb 1, 2023 · Completed: Aug 1, 2027
2 conditions
2 sponsors
1 location
NCT05498272
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations
PHASE2
Recruiting
32 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2026
5 conditions
3 sponsors
6 locations
NCT05751733
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
NA
Recruiting
258 participants
Started: Feb 1, 2023 · Completed: Jan 1, 2027
1 condition
2 sponsors
1 location
NCT06455072
Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer
PHASE2
Recruiting
37 participants
Started: Feb 1, 2023 · Completed: Jan 31, 2025
1 condition
2 sponsors
1 location
NCT05779254
SURGIcal COmplication and MIcrobiome ChangeS in Colorectal Surgery
N/A
Recruiting
100 participants
Started: Feb 1, 2023 · Completed: Jan 31, 2026
2 conditions
3 sponsors
3 locations
NCT05688020
Tranexamic Acid During Upper GI Endoscopic Resection Procedures
PHASE4
Recruiting
200 participants
Started: Feb 1, 2023 · Completed: Feb 28, 2026
4 conditions
1 sponsor
1 location
NCT05785793
Autoimmune Hepatitis Cohort in China
N/A
Recruiting
1,000 participants
Started: Feb 1, 2023 · Completed: Feb 1, 2028
1 condition
1 sponsor
1 location
NCT06241105
Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer
PHASE2
Recruiting
69 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT06976073
Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure
N/A
Recruiting
8,000 participants
Started: Feb 1, 2023 · Completed: Jan 1, 2026
5 conditions
1 sponsor
3 locations
NCT05327686
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
PHASE2
Recruiting
240 participants
Started: Feb 1, 2023 · Completed: Jun 15, 2028
4 conditions
2 sponsors
258 locations
NCT05708001
Improvement of Memory in Mild Cognitive Impairment
NA
Recruiting
40 participants
Started: Feb 1, 2023 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT05279287
Video Analysis of Errors and Technical Performance Within Minimally Invasive Surgery Short Title: Video Analysis in Minimally Invasive Surgery (VAMIS)
N/A
Recruiting
100 participants
Started: Feb 1, 2023 · Completed: Aug 31, 2024
2 conditions
3 sponsors
5 locations
NCT05222958
Effectiveness of an App for Tobacco Cessation in Pregnant Women (TOBBGEST)
NA
Recruiting
400 participants
Started: Feb 1, 2023 · Completed: May 30, 2026
1 condition
3 sponsors
1 location
NCT05154253
Augmenting Ankle Plantarflexor Function in Cerebral Palsy
PHASE1
Recruiting
36 participants
Started: Feb 1, 2023 · Completed: Sep 25, 2026
1 condition
3 sponsors
1 location
NCT06453538
Sleep Quality and Sleep-disordered Breathing in Bypass Surgery Patients
N/A
Recruiting
54 participants
Started: Feb 1, 2023 · Completed: Dec 30, 2025
2 conditions
1 sponsor
1 location
NCT06585722
Association Between Venous Excess Ultrasound Grading System and Acute Kidney Injury in the ICU Population
N/A
Recruiting
136 participants
Started: Feb 1, 2023 · Completed: Sep 5, 2024
3 conditions
1 sponsor
1 location
NCT05748717
Arterial Function Parameters and Transcranial Doppler Velocity in Paediatric Patients With Sickle Cell Disease
N/A
Recruiting
34 participants
Started: Feb 1, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05295212
Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB
PHASE2
Recruiting
120 participants
Started: Feb 1, 2023 · Completed: Jul 1, 2025
1 condition
1 sponsor
1 location
NCT06998381
Ethnic Specificities of S100B Protein Blood Level in Guadeloupe: Cross-sectional Study in Healthy Subjects
N/A
Recruiting
200 participants
Started: Feb 1, 2023 · Completed: Aug 1, 2025
1 condition
1 sponsor
2 locations
NCT05730023
A Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia, MAINSTREAM ID:3430931
NA
Recruiting
60 participants
Started: Feb 1, 2023 · Completed: Feb 28, 2026
1 condition
5 sponsors
4 locations
NCT05745181
Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic Lymphoma
PHASE2
Recruiting
20 participants
Started: Feb 1, 2023 · Completed: Jan 1, 2026
2 conditions
1 sponsor
1 location
NCT06992011
A Randomized Controlled Trial Comparing Clinical Effectiveness of SMILE Versus SMILE Xtra in Myopia
NA
Recruiting
300 participants
Started: Feb 1, 2023 · Completed: Feb 28, 2027
1 condition
1 sponsor
1 location
NCT05723003
Prospective Validation of an Acute Pulmonary Embolism Severity and Prognosis Prediction Model
N/A
Recruiting
4,000 participants
Started: Feb 1, 2023 · Completed: Oct 30, 2025
1 condition
1 sponsor
1 location
NCT05704582
RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders
NA
Recruiting
150 participants
Started: Feb 1, 2023 · Completed: Jan 31, 2028
3 conditions
2 sponsors
1 location
NCT05874310
Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
EARLY_PHASE1
Recruiting
18 participants
Started: Feb 1, 2023 · Completed: Nov 1, 2027
1 condition
4 sponsors
2 locations
NCT05891145
Remimazolam for Postoperative Atrial Fibrillation
NA
Recruiting
50 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06600945
Atracurium Versus Atracurium and Magnesium Sulphate As Adjuvants to Local Anesthetic
N/A
Recruiting
180 participants
Started: Feb 1, 2023 · Completed: Apr 1, 2025
1 condition
2 sponsors
1 location
NCT06067607
Examining the Effect of Eye Gaze Technology on Children With Cortical Visual Impairment
NA
Recruiting
10 participants
Started: Feb 1, 2023 · Completed: Apr 5, 2024
2 conditions
1 sponsor
1 location
NCT06508866
Timing And Typology of ConducTIon disturbanCes During TAVI
N/A
Recruiting
490 participants
Started: Feb 1, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05821166
Potential of Moderate Whole Body Hyperthermia to Enhance Response
PHASE2
Recruiting
80 participants
Started: Feb 1, 2023 · Completed: Dec 1, 2027
1 condition
1 sponsor
1 location
NCT05673031
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
N/A
Recruiting
500 participants
Started: Feb 1, 2023 · Completed: Jan 1, 2027
1 condition
1 sponsor
1 location
Previous
1
More pages
870
871
872
873
874
875
876
More pages
1333
Next